Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
- 6 Similar Profiles
Collaborations and top research areas from the last five years
-
An open-label study to assess the efficacy and safety of extended TARPEYO? (delayed-release budesonide capsules) treatment in adult patients with...
Klomjit, N. (PI)
10/29/25 → 4/14/36
Project: Research project
-
An open-label, non-randomized extension study to evaluate the long-term efficacy, safety and tolerability of iptacopan (LNP023) in C3 glomerulopathy or idiopathic immune-complex- membranoproliferative glomerulonephritis
Klomjit, N. (PI)
NOVARTIS PHARMACEUTICALS CORPORATION
3/1/25 → 1/5/30
Project: Research project
-
A multicenter, single-arm, open label trial to evaluate efficacy and safety of oral, twice daily LNP023 inadult atypical hemolytic uremic syndrome (aHUS) patients who are naive to complement inhibitor therapy
Klomjit, N. (PI)
NOVARTIS PHARMACEUTICALS CORPORATION
3/1/24 → 2/28/27
Project: Research project
-
multicenter, randomized, double-blind, parallel group, placebo-controlled study to evaluate the efficacyand safety of iptacopan (LNP023) in idiopathic immune complex mediated membranoproliferativeglomerulonephritis (IC-MPGN).
Klomjit, N. (PI)
NOVARTIS PHARMACEUTICALS CORPORATION
7/11/23 → 4/27/31
Project: Research project
-
Parameters Associated With Renal Recovery and Survival in Myeloma Patients With Acute Renal Failure to Cast Nephropathy
Ludwig, H., Dimopoulos, M. A., Terpos, E., Bernhard, S., Theodorakakou, F., Beksac, M., Cengiz-Seval, G., Leung, N., Arcaini, L., Mangiacavalli, S., Bridoux, F., Agis, H., Chaidos, A., Gay, F., Roccatello, D., Hilbe, W., Havasi, A., Derudas, D., Klomjit, N. & Jhaveri, K. D. & 2 others, , Jan 2026, In: American Journal of Hematology. 101, 1, p. 56-69 14 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Link opens in a new tab Scopus citations -
Successful treatment of resistant hypertension secondary to catecholamine-secreting glomus tumor
Agakishi, J., Pickthorn, S. & Klomjit, N., Jul 2026, In: American journal of hypertension. 39, 7, p. 931-934 4 p.Research output: Contribution to journal › Comment/debate › peer-review
-
Cancer treatment-associated hypomagnesemia: Analysis from a large pharmacovigilance database
Klomjit, N., Evans, R., Sise, M. E., Jhaveri, K. D., Gupta, S., Pirovano, M., Ortega, J. L., Alikhan, F. M., Api, C. & Chowdhury, R. B., Nov 2025, In: European Journal of Internal Medicine. 141, 106383.Research output: Contribution to journal › Letter › peer-review
Open Access1 Link opens in a new tab Scopus citations -
Diagnosis and management of immune checkpoint inhibitor–associated nephrotoxicity: a position statement from the American Society of Onco-nephrology
Herrmann, S. M., Abudayyeh, A., Gupta, S., Gudsoorkar, P., Klomjit, N., Motwani, S. S., Karam, S., Costa E Silva, V. T., Khalid, S. B., Anand, S., Kala, J., Leaf, D. E., Murakami, N., Rashidi, A., Wanchoo, R. & Kitchlu, A., Jan 2025, In: Kidney international. 107, 1, p. 21-32 12 p.Research output: Contribution to journal › Article › peer-review
49 Link opens in a new tab Scopus citations -
Factors Affecting D90 High-risk Clinical Target Volumes (HR-CTV dose) of Intracavitary and Interstitial Brachytherapy in Locally Advanced Cervical Cancer
Chitmanee, P., Sampaongen, T. & Klomjit, N., Jan 2025, In: Clinical Oncology. 37, 103701.Research output: Contribution to journal › Article › peer-review
1 Link opens in a new tab Scopus citations